Curis
CRIS
#10206
Rank
NZ$25.39 M
Marketcap
NZ$1.85
Share price
-2.63%
Change (1 day)
-64.68%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.13. In 2024 the company made an earnings per share (EPS) of NZ-$11.75 an increase over its 2023 EPS that were of NZ-$15.09.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-45.67%
2024NZ-$11.75-22.15%
2023NZ-$15.09-26.17%
2022NZ-$20.4422.3%
2021NZ-$16.71-25.37%
2020NZ-$22.39-30.93%
2019NZ-$32.42-2.02%
2018NZ-$33.09
2016NZ-$75.20-10%
2015NZ-$83.55138.1%
2014NZ-$35.0940%
2013NZ-$25.07-25%
2012NZ-$33.4266.67%
2011NZ-$20.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.27-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.96-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.60-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$3.98-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.65-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$18.78 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.36-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA